- Home
- MGIC vs INM Comparison
MGIC vs INM Comparison
Compare MGIC & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- INM
- Stock Information
- Founded
- MGIC 1983
- INM 1981
- Country
- MGIC Israel
- INM Canada
- Employees
- MGIC N/A
- INM N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- INM Health Care
- Exchange
- MGIC Nasdaq
- INM Nasdaq
- Market Cap
- MGIC 1.0B
- INM 4.3M
- IPO Year
- MGIC 1991
- INM N/A
- Fundamental
- Price
- MGIC $19.59
- INM $2.33
- Analyst Decision
- MGIC Buy
- INM
- Analyst Count
- MGIC 2
- INM 0
- Target Price
- MGIC $18.00
- INM N/A
- AVG Volume (30 Days)
- MGIC 41.5K
- INM 44.9K
- Earning Date
- MGIC 08-13-2025
- INM 11-13-2025
- Dividend Yield
- MGIC 2.82%
- INM N/A
- EPS Growth
- MGIC 16.93
- INM N/A
- EPS
- MGIC 0.78
- INM N/A
- Revenue
- MGIC $584,528,000.00
- INM $4,920,990.00
- Revenue This Year
- MGIC $11.11
- INM N/A
- Revenue Next Year
- MGIC $6.83
- INM N/A
- P/E Ratio
- MGIC $25.45
- INM N/A
- Revenue Growth
- MGIC 11.98
- INM N/A
- 52 Week Low
- MGIC $10.42
- INM $1.72
- 52 Week High
- MGIC $22.00
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- MGIC 44.17
- INM 54.08
- Support Level
- MGIC $19.79
- INM $2.03
- Resistance Level
- MGIC $20.80
- INM $2.28
- Average True Range (ATR)
- MGIC 0.48
- INM 0.08
- MACD
- MGIC -0.02
- INM -0.09
- Stochastic Oscillator
- MGIC 40.85
- INM 98.74
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.